1. Home
  2. OUST vs FLGT Comparison

OUST vs FLGT Comparison

Compare OUST & FLGT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OUST
  • FLGT
  • Stock Information
  • Founded
  • OUST 2015
  • FLGT 2011
  • Country
  • OUST United States
  • FLGT United States
  • Employees
  • OUST N/A
  • FLGT N/A
  • Industry
  • OUST Industrial Machinery/Components
  • FLGT Medical Specialities
  • Sector
  • OUST Technology
  • FLGT Health Care
  • Exchange
  • OUST Nasdaq
  • FLGT Nasdaq
  • Market Cap
  • OUST N/A
  • FLGT 508.7M
  • IPO Year
  • OUST N/A
  • FLGT 2016
  • Fundamental
  • Price
  • OUST $8.98
  • FLGT $16.90
  • Analyst Decision
  • OUST Buy
  • FLGT Hold
  • Analyst Count
  • OUST 8
  • FLGT 1
  • Target Price
  • OUST $13.71
  • FLGT $16.00
  • AVG Volume (30 Days)
  • OUST 1.5M
  • FLGT 739.8K
  • Earning Date
  • OUST 03-20-2025
  • FLGT 05-02-2025
  • Dividend Yield
  • OUST N/A
  • FLGT N/A
  • EPS Growth
  • OUST N/A
  • FLGT N/A
  • EPS
  • OUST N/A
  • FLGT N/A
  • Revenue
  • OUST $111,101,000.00
  • FLGT $283,470,000.00
  • Revenue This Year
  • OUST $33.58
  • FLGT $11.70
  • Revenue Next Year
  • OUST $53.02
  • FLGT $9.90
  • P/E Ratio
  • OUST N/A
  • FLGT N/A
  • Revenue Growth
  • OUST 33.41
  • FLGT N/A
  • 52 Week Low
  • OUST $5.84
  • FLGT $14.57
  • 52 Week High
  • OUST $16.88
  • FLGT $25.11
  • Technical
  • Relative Strength Index (RSI)
  • OUST 48.22
  • FLGT 49.28
  • Support Level
  • OUST $7.28
  • FLGT $16.51
  • Resistance Level
  • OUST $11.39
  • FLGT $17.20
  • Average True Range (ATR)
  • OUST 0.79
  • FLGT 0.56
  • MACD
  • OUST 0.16
  • FLGT -0.02
  • Stochastic Oscillator
  • OUST 37.31
  • FLGT 33.77

About FLGT Fulgent Genetics Inc.

Fulgent Genetics Inc is a technology company that focuses on genetic testing to provide physicians with clinically actionable diagnostic information. The company is engaged in laboratory services business and a therapeutic development business. The laboratory services business which generates key revenue includes, technical laboratory services and professional interpretation of laboratory results by licensed physicians. Its therapeutic development business is focused on developing drug candidates for treating a broad range of cancers. The geographical segments are the United States, which generates the vast majority of the revenue; and Foreign.

Share on Social Networks: